YATHARTH
Yatharth Hospital and Trauma Care Services Limited
Each stock's 10,000-path forecast, rendered as light.
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) Stock Analysis & Case Study
Is YATHARTH a good buy? The data-driven verdict.
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) trades at ₹858,on the numbers it tread carefully, a Downstox Snapshot Score of 33/100.
On the numbers, Yatharth Hospital and Trauma Care Services Limited (YATHARTH) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 47.1× earnings, ROE of 10.4%, a 55% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
YATHARTH fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How YATHARTH ranks against the 2,373 companies in our screener
- YATHARTH's market cap of 8,388 Cr ranks in the 73rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- YATHARTH's book value of ₹185 ranks in the 70th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- YATHARTH's promoter holding of 55.8% ranks in the 43rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- YATHARTH's 3-year profit (PAT) growth of 39.0% ranks in the 77th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- YATHARTH's 3-year revenue growth of 36.0% ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- YATHARTH's debt-to-equity ratio of 0.15x is lower than 69% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is YATHARTH overvalued? YATHARTH P/E vs peers
YATHARTH trades at 47.1× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
YATHARTH share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.9y of YATHARTH history (33%/yr drift, 39%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| YATHARTH 2027 | ₹554 | ₹912 | ₹1,501 | +5% |
| YATHARTH 2028 | ₹474 | ₹956 | ₹1,929 | +10% |
| YATHARTH 2029 | ₹421 | ₹1,002 | ₹2,383 | +15% |
| YATHARTH 2030 | ₹391 | ₹1,050 | ₹2,815 | +21% |
| YATHARTH 2031 | ₹368 | ₹1,100 | ₹3,285 | +26% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability YATHARTH goes up, or doubles?
The bull case for YATHARTH
- Yatharth Hospital and Trauma Care Services Limited is part of the nifty500 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹2,383.
The bear case & risks
- YATHARTH's P/E of 47.8x is lower than 28% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- YATHARTH's return on equity of 10.4% ranks in the 52nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹421.
YATHARTH volatility & expected range, how bumpy is the ride?
Over the last 2.9 years YATHARTH compounded at 33%/year with annualized volatility of 39%. That volatility implies a 1-year 80% range of ₹554-₹1,501, the honest backbone behind any single price target.
YATHARTH price forecast, the full 60-month probability fan
YATHARTH price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds YATHARTH hits common targets within the simulated horizon?
Full multi-horizon detail on the YATHARTH price target & forecast page.
YATHARTH Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. YATHARTH scores 5/8, mixed financial health.
YATHARTH MTF margin & leverage across 9 brokers
Margin Trading Facility lets you buy YATHARTH with part of the capital. Lower margin % = higher leverage. Rates compared across 9 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.00% | 2.9× |
| Zerodha | 32.24% | 3.1× |
| Groww | 32.36% | 3.1× |
| DhanCHEAPEST | 32.24% | 3.1× |
| Kotak Neo | 34.97% | 2.9× |
| Paytm Money | 32.54% | 3.1× |
| Pocketful | 32.75% | 3.1× |
| Anand Rathi | 32.24% | 3.1× |
| Share India | 32.35% | 3.1× |
Compare every broker on the YATHARTH MTF page.
About Yatharth Hospital and Trauma Care Services Limited: sector, index & market-cap context
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) is a small-cap NSE-listed company, with a market capitalisation of ₹8,268 Cr. See more stocks on our screener.
How the YATHARTH Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Yatharth Hospital and Trauma Care Services Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
YATHARTH analysis, FAQs
Is Yatharth Hospital and Trauma Care Services Limited (YATHARTH) a good buy?
On the numbers, Yatharth Hospital and Trauma Care Services Limited (YATHARTH) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 47.1× earnings, ROE of 10.4%, a 55% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is YATHARTH overvalued or undervalued?
YATHARTH trades at 47.1× earnings, expensive versus the ~22× long-run Nifty average.
What is the YATHARTH share price target for 2031?
YATHARTH's probability-weighted 2031 median target is ₹1,100, with an 80% range of ₹368-₹3,285 (10,000-path Monte-Carlo).
What is the probability YATHARTH doubles in 5 years?
The modelled probability of YATHARTH reaching ₹1,741 (2×) within 5 years is 29%.
What is the bull case for YATHARTH?
Yatharth Hospital and Trauma Care Services Limited is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in YATHARTH?
YATHARTH's P/E of 47.8x is lower than 28% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. YATHARTH's return on equity of 10.4% ranks in the 52nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.